Summary
H uman cytomegalovirus (HCMV) 1 is a major cause of morbidity and mortality in immunocompromised individuals. Studies using murine cytomegalovirus (MCMV), which serves as a useful animal model for HCMV, have demonstrated that MCMV infection provokes strong responses by both innate and specific arms of the immune system. However, even in the immunocompetent host, MCMV; ( a ) causes disseminated acute infection; ( b ) persistently produces infectious virus within the salivary gland for weeks to months after induction of specific immunity; and ( c ) establishes a life-long latent state. This suggests that the virus is able to evade or modify responses by the immune system.
Multiple components of the innate and specific immune responses are active during acute MCMV infection. IFN-␣ / ␤ , TNF-␣ , IL-12, and IFN-␥ contribute to the control of MCMV during initial stages of infection (1) (2) (3) (4) (5) . NK cells contribute to control of MCMV infection (6) through production of IFN-␥ (3, 4) and cytotoxicity (7) . Specific immune function is required for protection from virus-induced mortality (8) . CD8 T cells mediate clearance of infectious virus from most peripheral organs and confer protective immunity (9) . However, CD4 T cells can effectively clear MCMV infection from peripheral organs in the absence of CD8 T cells (10) . Clearance of MCMV from the salivary gland involves CD4 T cells (11) and IFN-␥ (1).
Both MCMV and HCMV have evolved mechanisms for evading CD8 T cells and NK cells. Both viruses inhibit 1038 MCMV Inhibition of IFN-␥ -induced MHC Gene Expression MHC class I expression on infected cells (12) (13) (14) (15) (16) . Similarly, both MCMV and HCMV interfere with NK cell activity through the actions of virally encoded MHC class I homologs (17, 18) . Since CD4 T cells are also essential for control of MCMV infection from salivary gland, it is not surprising that MCMV inhibits priming of CD4 T cells in vivo (19) . However, mechanisms underlying CMV-mediated inhibition of CD4 T cell activation have not been completely defined. HCMV-induced IFN-␤ , as well as direct infection, inhibits IFN-␥ -induced MHC class II expression in endothelial cells (20, 21) . HCMV also alters MHC class II expression in cultured human peripheral blood macrophages (M s; reference 22) . Similarly, MCMV-induced IFN-␣ / ␤ inhibits MHC class II expression on M s during the innate immune response (23) .
M s are important in the pathogenesis of both HCMV and MCMV. Key functions of M s include presentation of antigen to CD4 T cells via MHC class II and secretion of cytokines. M s are a site of MCMV replication in multiple sites (24) (25) (26) . Dissemination of MCMV (and likely HCMV) to secondary sites of infection is mediated by M s or Mlike cells within the blood (25) (26) (27) . Monocytes and M s are a site of long-term latency for HCMV and MCMV (28) (29) (30) (31) .
In these studies, MCMV impaired IFN-␥ -induced MHC class II-dependent antigen presentation by bone marrow (BM)M s. This effect was due to the failure of IFN-␥ to efficiently induce mRNAs for IA b , invariant chain (Ii), H-2Ma, and H-2Mb in infected cells, whereas quantities of transporter associated with antigen presentation (TAP)2 mRNA were unaltered by infection. This effect on MHC class II-mediated antigen presentation may contribute to the persistence of MCMV in the host, particularly in the salivary gland, where CD4 T cells play a critical role.
Materials and Methods
Animals, Media, and BMM Culture. 4-12-wk-old 129Ev/Sv and IFN ␣␤ receptor-deficient (IFNR-␣ / ␤ R Ϫ / Ϫ ) mice (32) were housed in a Biosafety Level 2 facility at Washington University in accordance with all Federal and University policies. Sentinel animals were negative for adventitious mouse pathogens by serology. Virus stocks were grown and diluted in low endotoxin ( Ͻ 0.025 ng/ml) DME containing 10% FCS (DME 10%; reference 3). BMM s were prepared as previously described (23) and were at least 95% F4/80 positive (data not shown). BMM cultures were mock infected or infected with MCMV or UV-inactivated MCMV, at a multiplicity of infection (MOI) of 5.0 unless otherwise stated, for 1 h at 37 Њ C in 5% CO 2 with rocking every 5 min. After infection, cells were treated with IFN-␥ (100 IU/ml; Genentech, San Francisco, CA) or medium alone for various periods of time while incubating at 37 Њ C in 5% CO 2 . Cells were harvested by scraping, then fixed, and analyzed for IA b expression by flow cytometry. BMM viability was determined by trypan blue exclusion.
Viruses and Viral Assays. MCMV (American Type Culture Collection [ATCC] No. VR-194, Lot 10) was grown, inactivated by UV irradiation, and titered by plaque assay in BALB/ 3T12-3 fibroblasts (ATCC, CCL 164; reference 3). Recombinant MCMV expressing bacterial ␤ -galactosidase (RM427; reference 25) was a gift of Dr. Edward Mocarski (Stanford University, Stanford, CA). 3T12 cells as well as MCMV stocks were negative for mycoplasma using the Mycoplasma TC test kit (Gen-Probe, San Diego, CA).
Analysis of Cell Surface Protein Expression. Flow cytometry was performed as previously described (3, 23) on an Epics flow cytometer (Coulter, Miami, FL) using XL analysis software (Coulter) or WinMDI 2.0 (Joseph Trotter, San Diego, CA). IA b high and low BMM were separated by fluorescent activated cell sorting on a FACS ® Vantage fluorescent activated cell sorter (Becton Dickinson, San Jose, CA). ␤ -galactosidase expression in sorted cells was detected by 5-bromo-4-chloro-3 indolyl-␤ -d -galactopyranoside staining (33) .
Supernatant Transfer Studies. Wild-type 129 BMM s were either mock infected or infected with MCMV for 48 h. Supernatants were ultracentrifuged for 30 min at 100,000 g to remove free virus as confirmed by plaque assay, and then placed on naive cultures of wild-type or IFN-␣ / ␤ R Ϫ / Ϫ BMM s at 2 ml/plate in 60-mm dishes (Sarstedt, Newton, NC) for 1 h. In additional groups, MCMV was added to the cultures at an MOI of 5.0. After 1 h of incubation, IFN-␥ (100 IU/ml) was added and culture volumes were raised to 3 ml with fresh medium. Cultures were incubated at 37 Њ C for 48 h and were assayed for IA b expression.
Electrophoretic Mobility Shift Assays. BMM s were either mock infected or infected with MCMV for 1 h at 37 Њ C. For STAT1 ␣ activation, cells were harvested at 1, 24, and 48 h after infection. 10 6 cells were suspended in endotoxin free PBS (Sigma Chemical Co., St. Louis, MO) containing 10% FCS, and were treated with IFN-␥ at concentrations ranging from 0.5 to 1,000 IU/ml for 10 min. Nuclear extracts were prepared and assayed by electrophoretic mobility shift assay (EMSA) against a 32 P-labeled oligonucleotide probe derived from the IFN-␥ activating sequence of the Fc ␥ RI promoter (34) . Anti-STAT1 super-shift assays were performed by incubation of 2 g of STAT1 (p91) specific antiserum (Santa Cruz Biotechnology, Santa Cruz, CA) with the nuclear extract/ probe mixture for 45 min at 25 Њ C before acrylamide gel electrophoresis. For analysis of IRF-1 DNA-binding activity, BMM were removed from medium containing L cell conditional medium (23) for 15 h before infection with MCMV for 1 h followed by treatment with IFN-␥ (100 IU/ml) for an additional 4 h. Nuclear extracts were generated from 10 6 cells (34) and assayed for IRF-1 DNA binding activity by EMSA using a 32 P-labeled oligonucleotide containing the IFN response factor (IRF)-E of the murine (2 Ј -5 Ј ) oligoadenylate synthase promoter (35) . Super-shift assays for IRF-1 were performed by adding 2 g of anti-murine IRF-1 polyclonal antisera (Santa Cruz Biotechnology) to mixtures of extract and probe and incubating at 25 Њ C for 45 min before analysis.
Northern Blot Analysis. Total cellular RNA was harvested from BMM cultures using RNAzol (Tel-Test Inc., Friendswood, TX) and analyzed by Northern blot hybridization (36) . PCR-derived probes used for these studies included a 300-bp fragment of the murine IA b beta chain (5 Ј -ccggaattcgccagtgcctccagaggtgacagtgtatc; 3 Ј -cgcggatccccatgccacagaaacaggtctcaggag), a rat ␤-actin fragment (5Ј-tatggagaagatttggcacc; 3Ј-gtccagacgcaggatggcat; gift of Dr. J. Milbrandt, Washington University) and a 226-bp fragment of mouse Ii p33 cDNA (5Ј-agctctgtacaccggtgtctctgtcc; 3Ј-gacattggacgcatcagcaagggag; gift of Dr. E. Unanue, Washington University, St. Louis, MO). The following cDNAs were also used to generate probes: murine IRF-1 (37), rat cyclophilin (38) , murine CD45 (provided by Dr. M. Thomas, Washington University), TAP1 (39), TAP2 (40) , H-2Ma, and H-2Mb (41) (the latter four gifts of Dr. J. Monaco, University of Cincinnati, Cincinnati, OH). All probes were radiolabeled using the 
Results

MCMV Inhibition of Antigen Presentation to CD4 T Cells. We examined IFN-␥-stimulated presentation of peptide antigen to CD4 T cells by primary BMMs after
infection with MCMV. Primary cells were used because previous studies of MCMV regulation of MHC class I expression had revealed differences between cell lines and primary cells (15) . Ms were either mock infected or infected with MCMV, treated with IFN-␥ for 24 h, fixed, and tested for the ability to present peptide antigen ( Fig. 1 A) . IFN-␥ treatment of Ms resulted in effective presentation of ␤-galactosidase peptide (429-441) to the T cell hybridoma B11, whereas MCMV infection abolished IFN-␥-induced antigen presentation. The antigen presenting cell, rather than the T cell hybridoma, was impaired by virus since (a) Ms were fixed before incubation with T cells, and (b) addition of fixed MCMV infected Ms did not efficiently inhibit the capacity of uninfected Ms to present peptide antigen (Fig. 1 A) . Cell surface IA b levels were evaluated by flow cytometry, since decreased IA b expression might explain defective antigen presentation. MCMVinfected Ms failed to respond to IFN-␥ stimulation by upregulation of cell surface IA b (Fig. 1 B) .
MCMV (Fig. 2) . Cell viability in the MCMV-infected M cultures was Ͼ95% at 72 h after infection. Live virus was required for inhibition of IA b expression, since UV-inactivated MCMV, even at a MOI of 6.0, had no effect on M IA b expression (Fig. 2) .
Inhibition of MHC Class II Induction Correlates with Direct Infection of Ms. MCMV-mediated inhibition of IFN-␥-induced IA b expression was dependent on viral dose (Fig. 2) , which suggested a role for direct infection. To address this possibility, IFN-␣/␤R Ϫ/Ϫ Ms were infected with RM427 (25), a recombinant MCMV expressing ␤-galactosidase under the MCMV ie1/ie2 promoter/enhancer at an MOI of 0.6, and treated with IFN-␥. Cells were fixed 48 h after infection, stained for IA b expression, and separated into IA b high and low populations by fluorescent activated cell sorting (Fig. 3 A) . IA b low Ms were enriched for ␤-galatosidase positive (infected) cells (Fig. 3, A and B) , whereas the IA b high cells were only 0.5-2.5% positive for ␤-galactosidase. This demonstrated that IA b expression is low in MCMVinfected BMMs. However, over several experiments, ␤-galactosidase was detected in Ͻ100% of IA b low cells, raising the possibility that a soluble mediator might contribute to low class II expression in ␤-galactosidase-negative cells.
To determine whether soluble factors played a role in MCMV's inhibition of IA b induction in IFN-␣/␤R Ϫ/Ϫ Ms, supernatant transfer studies were performed. Supernatants from wild-type 129 Ms infected with MCMV or mock infected for 48 h were ultracentrifuged to remove free virus and placed on naive M cultures derived from either wild-type 129 or IFN-␣/␤R Ϫ/Ϫ mice. IFN-␥ was added to these secondary cultures, and after 48 h, IA b expression was evaluated (Fig. 4) . As expected from our previous work (23), supernatant from MCMV-infected Ms inhibited IFN-␥-induced IA b expression on wild-type Ms, but not on IFN-␣/␤R Ϫ/Ϫ Ms (Fig. 4) , confirming that MCMV-induced IFN-␣/␤ can inhibit IFN-␥-induced MHC class II expression. However, there was no evidence for a soluble mediator affecting IA b expression in MCMVinfected IFN-␣/␤R Ϫ/Ϫ M cultures (Fig. 4) . Therefore, direct infection of the M, rather than a soluble mediator, is likely to explain MCMV's effects on MHC IA b expression.
MCMV Inhibits IFN-␥-induced MHC Class II and Invariant Chain mRNA Expression. IFN-␥ induction of MHC class II expression occurs at the level of gene transcription (45) , and studies in HCMV-infected endothelial cells have shown that HCMV infection regulates MHC class II mRNA levels (21) . We therefore evaluated MCMV's ef- (Fig. 5) .
Although a 6-8-fold reduction of IFN-␥-induced IA b mRNA accumulation within MCMV-infected cells explained a portion of the effects of MCMV infection on antigen presentation (Fig. 1 A) , it did not plausibly account for the at least 30-fold loss of cell surface expression of IA b (Figs. 1 B, 2, 3, 4) . Therefore, we examined the effect of MCMV on expression of another IFN-␥-inducible gene, Ii, which is essential for efficient cell surface expression of MHC class II (46, 47) . Northern blot hybridization showed that IFN-␥-induced Ii transcript levels are reduced 5-Ͼ10-fold at 24 h and Ͼ10-fold at 48 h in MCMV-infected BMM cultures. The combined effect of MCMV infection on IFN-␥-induced IA b and Ii mRNA accumulation plausibly explains most or all of the decreased MHC class II expression on MCMV-infected Ms.
To address the possibility that MCMV's reduction of IA b and Ii mRNA levels was due to a general effect on host mRNA, levels of several constitutive host mRNAs were evaluated. MCMV infection for up to 48 h did not significantly decrease levels of ␤-actin (Fig. 5, A and B) , cyclophilin (see Fig. 8 ), or CD45 (data not shown) mRNAs as measured against a 28S RNA loading control. In contrast, treatment of BMMs with actinomycin D for 5-10 h revealed diminished ␤-actin, cyclophilin, and CD45 mRNA levels compared to untreated cells (data not shown), demonstrating that the half lives of these mRNAs were short enough for us to detect significant MCMV induced alteration in their stability. Thus, inhibition of IFN-␥-induced IA b and Ii mRNA accumulation is not solely due to a general effect on mRNA levels by MCMV.
MCMV Does Not Alter IFN-␥ Induction of STAT1␣ DNA Binding Activity. IFN-␥ initiates a cascade of events that leads to MHC class II mRNA accumulation, any one of which could, a priori, be altered by MCMV infection. We examined the effect of MCMV on an essential early event in IFN-␥ receptor signaling, activation and nuclear translocation of the latent cytoplasmic transcription factor STAT1␣. Activation of STAT1␣ is essential for IFN-␥ induction of MHC class II expression (48) . Ms were either mock infected or infected with MCMV for 1, 24, or 48 h before stimulation with IFN-␥, preparation of nuclear extracts, and evaluation of STAT1␣ binding activity by EMSA (Fig. 6) . The presence of STAT1␣ in the activated complex was confirmed by super-shift with antibody against STAT1␣ (Fig. 6) , whereas antibody to IRF-1 did not result in retardation of the complex (data not shown). IFN-␥ treatment resulted in comparable levels of STAT1␣ DNA binding activity in both mock-and MCMV-infected Ms, at 1, 24 (Fig. 6) , and 48 (data not shown) h after in- fection. STAT1␣ activation was also equivalent in mockand MCMV-infected Ms after treatment with IFN-␥ at doses as low as 0.5 IU/ml (data not shown). We conclude that the IFN-␥ signaling pathway remains intact through STAT1␣ activation in MCMV-infected BMMs.
MCMV Effects on IFN-␥ Induction of IRF-1.
To directly assess the effects of MCMV on the transactivating function of STAT1, we examined IFN-␥ induction of IRF-1 mRNA and protein. IRF-1 is rapidly induced at the transcriptional level after IFN-␥ stimulation in a STAT1␣-dependent manner (48) , with maximal mRNA expression by 2 h of cytokine treatment (49) . Ms were mock infected or infected with MCMV at an MOI of 5.0 for 3 h and treated with IFN-␥ (100 IU/ml) for the final 2 h of infection. Northern blot analysis showed that induction of IRF-1 mRNA accumulation by IFN-␥ in MCMV-infected Ms was 70-90% that of uninfected cells (Fig. 7 A) . To assess MCMV effects on expression of IRF-1 protein, we assayed nuclear extracts of Ms that were mock or MCMV infected for a total of 5 h, with IFN-␥ treatment during the final 4 h for binding to the IRF-E element of the murine (2Ј-5Ј) oligoadenylate synthase promoter (35) by EMSA. IFN-␥ treatment induced IRF-1 DNA binding activity in MCMV-infected cells (Fig. 7 B) as confirmed by super-shift of the complex after incubation with anti-IRF-1, but not anti-STAT1␣, antiserum. IFN-␥-induced IRF-1 DNA binding activity was decreased by at most 50% in MCMVinfected Ms compared to mock-infected Ms. IRF-1 DNA binding activity could also be induced by IFN-␥ in Ms that had been infected with MCMV for 24 h (data not shown).
MCMV Inhibits IFN-␥ Induction of Specific MHC Genes.
To assess the specificity of the block of IFN-␥ signaling caused by MCMV infection, we examined levels of several IFN-␥-induced transcripts in addition to IA b , Ii, and IRF-1. IFN-␣/␤R Ϫ/Ϫ Ms were infected with MCMV or UV-inactivated virus, or mock infected for 24 or 48 h in the presence or absence of IFN-␥, and mRNA levels were analyzed by Northern blot hybridization. IFN-␥ induction of H-2Ma and H-2Mb expression was significantly inhibited by MCMV at 24 h (Fig. 8) , whereas IFN-␥-induced TAP1 mRNA levels were decreased to a lesser extent. However, TAP2 mRNA levels were not significantly decreased by MCMV infection (Fig. 8) . Northern blot data from 48-h infections were similar to that of 24-h infections (data not shown). The lack of effect on IFN-␥ induction of TAP2 transcript levels by MCMV demonstrated that MCMV selectively affects expression of a subset of IFN-␥-inducible genes.
Discussion
CD4 T cells are required for clearance of salivary gland MCMV infection (11), yet infectious virus is found in the salivary gland for many weeks after acute infection, suggesting that MCMV antagonizes CD4 T cell function in some manner. It has also been shown that MCMV impairs CD4 T cell priming in vivo (19) while another IFN-␥-inducible MHC gene was largely unaffected.
Effects of MCMV on MHC Class II Antigen Presentation. MCMV impaired the ability of IFN-␥ to induce expression of mRNAs encoding multiple genes important for antigen presentation to CD4 T cells. These genes included the MHC class II allele IA b , as well as the Ii p33 subunit and the peptide-loading protein subunits H-2Ma and H-2Mb. Although the 6-8-fold reduction of IFN-␥-induced IA b mRNA levels observed in the setting of MCMV infection undoubtedly contributed to loss of cell surface expression of IA b (e.g., Fig. 1 B) , it was possible that additional factors accounted for the near complete inhibition of IA b expression. Ii is required for maximal cell surface expression of MHC class II proteins (46, 47) , and induction of Ii by IFN-␥ was significantly inhibited in MCMV-infected cells. Decreased expression H-2Ma and H-2Mb might also contribute to impaired MHC class II peptide presentation, since these proteins are necessary for optimal loading of peptide onto MHC class II molecules (50-52). However, loss of H-2Ma and H-2Mb expression probably did not contribute to decreased detection of cell surface IA b , as the antibody 25-9-17S detects IA b loaded with the class II Ii-associated peptide, CLIP (50) (51) (52) .
Implications of ␤-herpesvirus Impairment of Antigen Presentation to CD4 T Cells. Three lymphocyte classes (CD4 and CD8 T cells, and NK cells) are important for resistance to CMV during acute infection. CD8 T cells promote MCMV clearance and mediate protective immunity (9) , and are also important for control of HCMV (53) . As a countermeasure, both MCMV and HCMV inhibit antigen presentation to CD8 T cells by limiting MHC class I protein-dependent antigen presentation (12) (13) (14) (15) (16) . HCMV and MCMV prevent decreased expression of MHC class I on infected cells from triggering NK cells via expression of cell surface MHC class I homologs (17, 18) . CD4 T cells and IFN-␥ are important for clearance of virus from the salivary gland (1, 11) , but priming of CD4 T cells is inhibited in MCMV-infected mice (19) . The findings in this paper delineate a potential mechanism by which MCMV might impair CD4 T cell activation and avoid recognition by this third important class of lymphocytes.
We believe that viral impairment of IFN-␥-induced antigen presentation by Ms in particular has important implications for acute and chronic MCMV pathogenesis. Ms are involved in dissemination of MCMV and HCMV (25) (26) (27) ) and yet they are activated by IFN-␥ during acute MCMV infection (3, 23) . IFN-␥ inhibits MCMV growth in Ms and other cells (3, 54, 55) . How then does the virus disseminate in a cell activated by an anti-viral cytokine? We propose that signaling by IFN-␥ is inhibited in Ms if the virus is able to infect them and express protein before activation by IFN-␥. This would allow the virus to take advantage of the mobility of the Ms for dissemination, while minimizing the effects of IFN-␥ on viral growth and enhancement of immune induction. Our hypothesis is supported by the observation that M-like cells that disseminate MCMV are MHC class II negative (25) , whereas the majority of Ms responding to MCMV in inflammatory exudates from immunocompetent mice express high levels of MHC class II and are uninfected (3, 23) . Furthermore, we have preliminary data for a role of IFN-␥ in controlling chronic MCMV infection (Presti, R., J. Pollock, and H.W. Virgin, unpublished data). Since one site of MCMV and HCMV latency is cells of the monocyte/M lineage, interference with IFN-␥ signaling in latently infected cells may permit viral escape from IFN-␥'s antiviral effects, allowing reactivation and subsequent growth.
Mechanism of Inhibition of IFN-␥ Induction of MHC Gene Expression. We found that MCMV infection inhibits expression of specific IFN-␥-induced genes. Other viruses such as adenovirus have also been shown to alter IFN-mediated gene induction. Adenovirus protein E1A may block IFN-␣ signaling by inhibition of STAT2-dependent transactivation involving p300/CBP (56) . In our studies, MCMV inhibited IFN-␥ signaling distal to STAT1␣ activation since induction of STAT1␣ DNA binding activity was normal in infected cells, and mRNA levels of IRF-1, a gene transactivated by STAT1␣ were also near normal early after IFN-␥ treatment. Constitutive and inducible expression of MHC class II, H-2Ma, H-2Mb, and Ii are dependent on the class II transactivator (CIITA) (57) (58) (59) (60) . MCMV significantly inhibits induced expression of all of these genes. Therefore, one may speculate that a mechanism of viral action is the specific impairment of expression or function of CIITA.
Although there is a formal possibility that MCMV exerts its effect at the level of mRNA stability, we doubt this for two reasons. First, we saw little evidence of a general effect of MCMV on mRNA stability in the presence or absence of IFN-␥ over multiple experiments based on comparisons of cyclophilin, ␤-actin, and CD45 mRNA levels. Second, the effects of MCMV are specific to certain MHC genes. Thus, if MCMV infection interferes with IFN-␥ induction of MHC genes by destabilizing mRNAs, one would have to argue that the effects are specific for certain transcripts (e.g., IA b and Ii but not TAP2, ␤-actin, or cyclophilin).
We have documented a novel mechanism of immune avoidance by CMV, selective blockade of IFN-␥ induction of genes involved in antigen presentation to CD4 T cells. Further characterization of MCMV's block on IFN-␥ signaling, and identification of the viral genes involved will likely enhance understanding of CMV pathogenesis and the antiviral functions of the immune system.
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